Literature DB >> 407966

Salbutamol-induced diabetic ketoacidosis.

D J Thomas, B Gill, P Brown, W A Stubbs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 407966      PMCID： PMC1631218          DOI： 10.1136/bmj.2.6084.438

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  3 in total

1.  Metabolic responses to selective beta-adrenergic stimulation in man.

Authors:  R Goldberg; M van As; B I Joffe; L Krut; I Bersohn; H C Seftel
Journal:  Postgrad Med J       Date:  1975-02       Impact factor: 2.401

2.  Comparative hyperglycemic responses to norepinephrine salbutamol and glucagon in normal and alloxan-diabetic insulin-controlled rabbits.

Authors:  D E Potter; J Moratinos; S Ellis
Journal:  Arch Int Pharmacodyn Ther       Date:  1974-06

3.  Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man.

Authors:  H Imura; Y Kato; M Ikeda; M Morimoto; M Yawata
Journal:  J Clin Invest       Date:  1971-05       Impact factor: 14.808
  3 in total
  10 in total

Review 1.  Effects of drugs on glucose tolerance in non-insulin-dependent diabetics (Part II).

Authors:  S O'Byrne; J Feely
Journal:  Drugs       Date:  1990-08       Impact factor: 9.546

2.  Actions of salbutamol in late pregnancy: plasma cyclic AMP, insulin and C-peptide, carbohydrate and lipid metabolites in diabetic and non-diabetic women.

Authors:  B B Fredholm; N O Lunell; B Persson; J Wager
Journal:  Diabetologia       Date:  1978-04       Impact factor: 10.122

3.  Management of premature labour in diabetic pregnancy.

Authors:  A H Barnett; S M Stubbs; A M Mander
Journal:  Diabetologia       Date:  1980-05       Impact factor: 10.122

4.  Effect of dobutamine on insulin requirement in diabetic ketoacidosis.

Authors:  S M Wood; J R Milne; S F Evans; P Rogers
Journal:  Br Med J (Clin Res Ed)       Date:  1981-03-21

Review 5.  Drug-Induced Hyperglycaemia and Diabetes.

Authors:  Neila Fathallah; Raoudha Slim; Sofien Larif; Houssem Hmouda; Chaker Ben Salem
Journal:  Drug Saf       Date:  2015-12       Impact factor: 5.606

6.  Metabolic and hormonal effects of preferential beta 1 and beta 2-adrenoceptor stimulation in man.

Authors:  C Tantucci; F Santeusanio; M Beschi; M Castellano; C Sorbini; V Grassi
Journal:  J Endocrinol Invest       Date:  1988-04       Impact factor: 4.256

Review 7.  Catecholamines: role in health and disease.

Authors:  R Laverty
Journal:  Drugs       Date:  1978-11       Impact factor: 9.546

8.  Differences between acute and long-term metabolic and endocrine effects of oral beta-adrenoceptor agonist therapy with pirbuterol for cardiac failure.

Authors:  R Canepa-Anson; J R Dawson; P Kuan; P A Poole-Wilson; G C Sutton; B Cockrill; S R Reuben
Journal:  Br J Clin Pharmacol       Date:  1987-02       Impact factor: 4.335

9.  Effects of acetylsalicylic acid on plasma glucose, free fatty acid, betahydroxybutyrate, glucagon and C-peptide responses to salbutamol in insulin-dependent diabetic subjects.

Authors:  D Giugliano; N Passariello; R Torella; T Cerciello; M Varricchio; S Sgambato
Journal:  Acta Diabetol Lat       Date:  1981

10.  Metabolic and cardiovascular side effects of the beta 2-adrenoceptor agonists salbutamol and rimiterol.

Authors:  P J Phillips; A E Vedig; P L Jones; M G Chapman; M Collins; J B Edwards; T C Smeaton; B M Duncan
Journal:  Br J Clin Pharmacol       Date:  1980-05       Impact factor: 4.335
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.